Dodecanol

Dodecanol

SCHEMBL28693387

CCCCCCCCCCCCO.COC(=O)C1CNC(=O)C1

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC5A1 P13866 2/20 0.41
NAAA Q02083 5/20 0.39
DNTT P04053 2/20 0.37
LMNA P02545 2/20 0.36
TSHR P16473 2/20 0.36
ALDH1A1 P00352 1/20 0.36
HSD17B10 Q99714 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
POLB P06746 1/20 0.36
POLA1 P09884 1/20 0.36
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
PDE4A P27815 2/20 0.35
PDE4B Q07343 2/20 0.35
PDE4C Q08493 2/20 0.35
PDE4D Q08499 2/20 0.35
BRD4 O60885 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1026647 0.83 BRD4 (0.46) KMT2APDE4APDE4BPDE4CPDE4D
SCHEMBL22279768 0.83 BRD4 (0.46) KMT2APDE4APDE4BPDE4CPDE4D
SCHEMBL7542550 0.80 NAAA (0.50) SLC5A1NAAALMNATSHRALDH1A1
SCHEMBL7542860 0.80 NAAA (0.50) SLC5A1NAAALMNATSHRALDH1A1
Acetic Acid Methyl Ester SCHEMBL9151328 0.79 BRD4 (0.42) SLC5A1ALDH1A1KMT2ABRD4
Decane SCHEMBL8084226 0.77 SLC5A1 (0.46) SLC5A1NAAAALDH1A1
Propene SCHEMBL7744011 0.76 BRD4 (0.40) SLC5A1KMT2APDE4APDE4BPDE4C
SCHEMBL7744093 0.74 PDE4A (0.37) SLC5A1ALDH1A1PDE4APDE4BPDE4C
SCHEMBL8262495 0.67 CHRNB2 (0.43) SLC5A1SMN1; SMN2BRD4
SCHEMBL25041425 0.66 SLC5A1 (0.44) SLC5A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113797180-A Percutaneous absorption preparation containing donepezil as active ingredient Icure药品株式会社 2021-12-17 CN disclosed